Lexicon Pharmaceuticals logo
Lexicon Pharmaceuticals LXRX
$ 0.72 -0.33%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Lexicon Pharmaceuticals Financial Statements 2011-2024 | LXRX

Annual Financial Statements Lexicon Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

469 M 456 M 574 M - 340 M 467 M 1.16 B 1.42 B 1.06 B 486 M 939 M 1.03 B 508 M

Shares

221 M 166 M 146 M - 106 M 106 M 105 M 104 M 104 M 76.3 M 73.3 M 70 M 48.7 M

Historical Prices

2.12 2.75 3.94 3.42 4.15 6.64 9.88 13.8 13.3 6.37 12.6 15.5 9.03

Net Income

-177 M -102 M -87.8 M -58.6 M 130 M -121 M -129 M -141 M -4.68 M -100 M -104 M -110 M -116 M

Revenue

1.2 M 139 K 298 K 24 M 322 M 63.2 M 90.3 M 83.3 M 130 M 22.9 M 2.22 M 1.09 M 1.85 M

Cost of Revenue

85 K - - 1.93 M 3.23 M 2.49 M 1.9 M - - - - - -

Gross Profit

- - - - 319 M 60.7 M 88.4 M - - - - - 1.85 M

Operating Income

-172 M -101 M -87.1 M -47.8 M 141 M -103 M -131 M -127 M 1.47 M -100 M -102 M -108 M -114 M

Interest Expense

7.73 M 1.6 M 134 K 14.5 M 20.7 M 20.8 M 6.98 M 6.57 M 6.72 M 2.25 M 1.97 M 2.11 M 2.53 M

EBITDA

-171 M -100 M -86.8 M -44.9 M 174 M -99.6 M -131 M -136 M 11.7 M -83.9 M -102 M -94.3 M -109 M

Operating Expenses

- - - 204 M 149 M 164 M 223 M 221 M 119 M 109 M 107 M 99.6 M 116 M

General and Administrative Expenses

114 M 48.1 M 32.3 M 47.2 M - 63.8 M 66.2 M 43 M 23.8 M 19.4 M 17.1 M 17 M -

All numbers in USD currency

Quarterly Income Statement Lexicon Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

361 M 311 M 245 M 245 M 205 M 189 M - 175 M 150 M 149 M - 146 M 144 M 143 M - 107 M 107 M 107 M - 106 M 106 M 106 M 106 M 106 M 106 M 106 M 106 M 106 M 105 M 104 M 104 M 104 M 104 M 104 M 104 M 104 M 104 M 104 M 84.8 M 73.5 M 73.5 M 514 M 514 M 513 M 513 M 512 M 508 M 490 M 481 M 480 M 350 M 338 M 338 M 338 M

Net Income

-64.8 M -53.4 M -48.4 M -50.5 M -44.9 M -31.9 M - -23.4 M -24.6 M -23.5 M - -23.1 M -18.1 M -21 M - 82.6 M -69.1 M -66.6 M -51.1 M 226 M -23 M -44.8 M -16.8 M -27.4 M -34.5 M -41.8 M -26.6 M -29.8 M -34.7 M -31.9 M -32.4 M -36 M -38.1 M -34.9 M 86.8 M -35.3 M -28.1 M -28.1 M -2.93 M -40.5 M -26 M -30.8 M -17.4 M -31.7 M -29.1 M -26 M -24.9 M -29.5 M -25.9 M -29.9 M -33.8 M -26.1 M -26.6 M -29.6 M

Revenue

1.75 M 1.65 M 1.13 M 162 K 317 K 24 K - 39 K 35 K - - 23 K 234 K 27 K - 6.63 M 9.16 M 8 M 8.73 M 294 M 9.68 M 18.9 M 17.1 M 6.97 M 13.8 M 25.4 M 33 M 26.9 M 12.1 M 18.3 M 23 M 27.7 M 20.1 M 12.5 M 127 M 566 K 376 K 1.79 M 21.5 M 419 K 676 K 277 K 1.41 M 238 K 214 K 360 K 218 K 372 K 199 K 300 K 343 K 355 K 555 K 596 K

Cost of Revenue

71 K 166 K 31 K 7 K 8 K - - - - - - - - - - 633 K 728 K 568 K - 577 K 1.33 M 1.88 M - 551 K 838 K 533 K - 599 K 537 K - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-63.7 M -55.4 M -45.3 M -49.6 M -44.2 M -31.1 M - -23.1 M -24 M -23.4 M - -23 M -18 M -20.8 M - 86.7 M -64.6 M -62.4 M -47.2 M 225 M -18.5 M -36 M -12.4 M -22.9 M -30.3 M -37.7 M -29 M -28.6 M -33.5 M -39.5 M -31.3 M -34.9 M -37 M -33.9 M 88.4 M -33.7 M -26.7 M -26.5 M -3.45 M -40.3 M -26.1 M -30.5 M -17 M -31.2 M -28.6 M -25.6 M -24.5 M -29.1 M -25.5 M -29.4 M -33.3 M -25.7 M -25.9 M -29.1 M

Interest Expense

3.44 M 4.14 M 1.88 M 3 M 1.3 M 1.03 M - 864 K 703 K 110 K - 171 K 169 K 167 K - 4.12 M 5.12 M 5.13 M - 5.2 M 5.16 M 10.3 M - 5.25 M 5.19 M 5.11 M - 1.62 M 1.61 M 1.59 M - 1.65 M 1.64 M 1.65 M - 1.69 M 1.66 M 1.7 M - 449 K 455 K 457 K - 492 K 496 K 506 K - 527 K 530 K 537 K - 560 K 810 K 607 K

EBITDA

- - -45.2 M - - -31 M - -22.8 M -24 M -23.3 M - -22.8 M -18 M -20.8 M - 89.3 M -62.8 M -61.5 M -47.2 M 227 M -18.5 M -34.2 M -12.4 M -20.2 M -28.4 M -36.8 M -29 M -26.1 M -31.9 M -38.9 M -31.3 M -33.4 M -36 M -33.4 M 88.4 M -33 M -26.1 M -26.2 M -3.45 M -38.6 M -24.9 M -29.8 M -17 M -29 M -27 M -24.8 M -24.5 M -25.8 M -23.3 M -28.3 M -33.3 M -21.9 M -23.4 M -27.8 M

Operating Expenses

- - - - - -31.2 M - -23.1 M - 23.4 M - 23 M 18.2 M 20.9 M - 52.8 M 73.7 M 70.4 M - 69.8 M 28.2 M 54.9 M - 29.9 M 44.1 M 63.1 M - 56.5 M 45.9 M 60.8 M - 62.6 M 57.1 M 46.4 M - 34.2 M 27.1 M 28.3 M - 40.8 M 26.8 M 30.7 M - 31.5 M 28.8 M 25.9 M - 29.4 M 25.7 M 29.7 M - 26 M 26.5 M 29.7 M

General and Administrative Expenses

39.6 M 39.2 M 32.1 M 32.2 M 30 M 19.1 M - 12.6 M - - - - - - - - - - - - - - - - - 14.9 M - 16.7 M 18.5 M 14.9 M - 12.3 M 8.42 M 8.4 M - 5.38 M 6.31 M 5.7 M - 4.62 M 5.15 M 5.65 M - 4.72 M 4.67 M 4.32 M - 4.4 M 4.16 M 4.56 M - 4.06 M 4.53 M 4.75 M

All numbers in USD currency